Clinical Trial Update: Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D) [NA]

View source ↗

Summary

Clinical trial update for duodenal mucosal resurfacing (DMR) with the Revita system in type 2 diabetes shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Revita System

Snippet

Sponsor: Fractyl Health Inc. | Conditions: Diabetes Mellitus, Type 2, Noninsulin-Dependent Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2021-05-25